BioMS MBP8298 positive review

A board to discuss future MS therapies in early stage (Phase I or II) trials.

BioMS MBP8298 positive review

Postby dignan » Thu Oct 27, 2005 10:19 am

Good news for MBP8298 Phase II/III trial...



Data Safety Monitoring Board gives positive review for BioMS Medical's pivotal MS trial

October 27 - CNW - BioMS Medical Corp., a leading developer in the treatment of multiple sclerosis (MS), announced that following the second meeting of its independent Data Safety Monitoring Board (DSMB), the Company has received a recommendation to continue its pivotal phase II/III clinical trial for MBP8298 for the treatment of secondary progressive multiple sclerosis. This second recommendation by the DSMB members was based on their recent review of the safety data from patients who have been dosed in the pivotal phase II/III clinical study.

"This recommendation represents solid and steady progress of our lead drug candidate MBP8298," said Kevin Giese, President of BioMS Medical. "MBP8298 is indeed the most advanced drug candidate in clinical testing for secondary progressive MS. Accordingly, we are pleased with the safety profile obtained in patients up to this point."

This was the second of several regularly scheduled reviews by the DSMB that will occur over the duration of the trial. The purpose of the DSMB is to provide objective, independent safety monitoring of the trial. The pivotal phase II/III study is now ongoing at trial sites across Canada, the U.K. and Sweden.

About BioMS Medical Corp.
BioMS Medical Corp. is a biotechnology company dedicated to the development and commercialization of innovative therapies. BioMS Medical's lead drug, MBP8298, is a patented technology for the treatment of multiple sclerosis and is currently in a pivotal Phase II/III clinical trial. The Company is poised to initiate a Phase I clinical trial for HYC750, a therapeutic designed to mobilize stem cells and neutrophils for the treatment of cancer therapy related side-effects. BioMS also has an equity interest in BioCyDex, a private company developing technology for the delivery of drugs into cells.

http://biz.yahoo.com/cnw/051027/bioms_m ... .html?.v=1
User avatar
dignan
Family Elder
 
Posts: 1608
Joined: Wed Aug 11, 2004 2:00 pm

Advertisement

Return to Drug Pipeline

 


  • Related topics
    Replies
    Views
    Last post
  • BioMS Medical
    by adjanimals » Tue Oct 26, 2004 8:00 am
    0 Replies
    1334 Views
    Last post by adjanimals View the latest post
    Tue Oct 26, 2004 8:00 am
  • BioMS update
    by dignan » Mon Nov 12, 2007 9:05 am
    0 Replies
    1180 Views
    Last post by dignan View the latest post
    Mon Nov 12, 2007 9:05 am
  • MBP8298
    by dignan » Wed May 03, 2006 6:52 am
    5 Replies
    2670 Views
    Last post by dignan View the latest post
    Thu Jun 22, 2006 7:24 am
  • MBP8298
    by bromley » Thu Sep 07, 2006 8:48 am
    1 Replies
    1216 Views
    Last post by gwa View the latest post
    Thu Sep 07, 2006 9:51 am
  • MBP8298
    by bromley » Thu Oct 12, 2006 10:39 am
    0 Replies
    1059 Views
    Last post by bromley View the latest post
    Thu Oct 12, 2006 10:39 am

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service